Gabriel Schwartz, MSN, NP, explains how mechanisms of action determine the safety of systemic treatments in metastatic colorectal cancer post chemotherapy.
Systemic Treatment of mCRC Post Standard Chemotherapy
Advertisement
Advertisement
Trending on Oncology Nursing News
1
How An Adaptive Weight-Loss Strategy Benefits Breast Cancer Survivors
2
Cancer Surgery Waiting Times Rising: What Oncology Nurses Need to Know
3
Advances in Lymphoma Care: Experts Breakdown CAR T-Cell Therapy, Bispecifics, and CLL Management
4
Active Surveillance Rates Rise for Prostate Cancer in Veterans Health System
5